BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33051650)

  • 1. Antifungal Susceptibility Does Not Correlate With Fungal Clearance or Survival in AIDS-Associated Cryptococcal Meningitis.
    O'Connor L; Van Anh D; Chau TTH; Chau NVV; Huong LNP; Wolbers M; Day JN
    Clin Infect Dis; 2021 Oct; 73(7):e2338-e2341. PubMed ID: 33051650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
    Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
    Jaruratanasirikul S
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for cryptococcal meningitis in patients with AIDS.
    Powderly WG
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S54-9. PubMed ID: 1562696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole-resistant cryptococcal meningitis.
    Momoff N; Parrish A
    S Afr Med J; 2003 Jun; 93(6):444. PubMed ID: 12916384
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination antifungal therapy for cryptococcal meningitis.
    Day JN; Chau TTH; Wolbers M; Mai PP; Dung NT; Mai NH; Phu NH; Nghia HD; Phong ND; Thai CQ; Thai LH; Chuong LV; Sinh DX; Duong VA; Hoang TN; Diep PT; Campbell JI; Sieu TPM; Baker SG; Chau NVV; Hien TT; Lalloo DG; Farrar JJ
    N Engl J Med; 2013 Apr; 368(14):1291-1302. PubMed ID: 23550668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
    Larsen RA; Bauer M; Thomas AM; Graybill JR
    Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.
    Witt MD; Lewis RJ; Larsen RA; Milefchik EN; Leal MA; Haubrich RH; Richie JA; Edwards JE; Ghannoum MA
    Clin Infect Dis; 1996 Feb; 22(2):322-8. PubMed ID: 8838190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
    Loyse A; Burry J; Cohn J; Ford N; Chiller T; Ribeiro I; Koulla-Shiro S; Mghamba J; Ramadhani A; Nyirenda R; Aliyu SH; Wilson D; Le T; Oladele R; Lesikari S; Muzoora C; Kalata N; Temfack E; Mapoure Y; Sini V; Chanda D; Shimwela M; Lakhi S; Ngoma J; Gondwe-Chunda L; Perfect C; Shroufi A; Andrieux-Meyer I; Chan A; Schutz C; Hosseinipour M; Van der Horst C; Klausner JD; Boulware DR; Heyderman R; Lalloo D; Day J; Jarvis JN; Rodrigues M; Jaffar S; Denning D; Migone C; Doherty M; Lortholary O; Dromer F; Stack M; Molloy SF; Bicanic T; van Oosterhout J; Mwaba P; Kanyama C; Kouanfack C; Mfinanga S; Govender N; Harrison TS
    Lancet Infect Dis; 2019 Apr; 19(4):e143-e147. PubMed ID: 30344084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
    Vidal JE; de Albuquerque Moraes C; de Siqueira REB; Miranda NFB; Marcusso R; Boulware DR; de Oliveira ACP
    Mycopathologia; 2021 Mar; 186(1):93-102. PubMed ID: 33258083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
    Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
    Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in managing HIV-associated cryptococcal meningitis.
    Boyer-Chammard T; Temfack E; Alanio A; Jarvis JN; Harrison TS; Lortholary O
    F1000Res; 2019; 8():. PubMed ID: 31275560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of sequential treatment with amphotericin B-fluorocytosine and fluconazole in cryptococcal meningitis not associated with AIDS].
    Pintado García V; Martín Dávila P; Muñoz Labián V; Quereda Rodríguez-Navarro C
    Rev Clin Esp; 1999 Jul; 199(7):480. PubMed ID: 10481571
    [No Abstract]   [Full Text] [Related]  

  • 16. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
    de Gans J; Portegies P; Tiessens G; Eeftinck Schattenkerk JK; van Boxtel CJ; van Ketel RJ; Stam J
    AIDS; 1992 Feb; 6(2):185-90. PubMed ID: 1313682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
    Yao ZW; Lu X; Shen C; Lin DF
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1339-44. PubMed ID: 24550039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole and amphotericin B for cryptococcal meningitis.
    Clark AB; Lobo BL; Gelfand MS
    Ann Pharmacother; 1996 Dec; 30(12):1408-10. PubMed ID: 8968453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of fluconazole in the treatment of non-AIDS cryptococcal meningitis.
    Antony SJ; Patel A; Leonard J
    J Natl Med Assoc; 1997 Oct; 89(10):694-5. PubMed ID: 9347685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.